Abstract: Aspects of the subject technology relate to gaze-dependent visual encryption of electronic device displays. Each display frame that is displayed on the electronic device display may include a clear-display region around the user's gaze location and an obscured region outside the clear-display region. In this way, only the display content that the user is actively viewing is recognizable and understandable and an onlooker such as an unwanted observer looking over the user's shoulder is unable to understand what is displayed. The obscured region of each display frame may be generated such that the overall look and structure of that region is unchanged, but the content is unintelligible. In this way, the visual experience of the user is not disrupted or distracted by the visual encryption and the eye of the onlooker is not guided to the clear-display region by the visual encryption.

Abstract: Aspects of the subject technology relate to gaze-dependent visual encryption of electronic device displays. Each display frame that is displayed on the electronic device display may include a clear-display region around the user's gaze location and an obscured region outside the clear-display region. In this way, only the display content that the user is actively viewing is recognizable and understandable and an onlooker such as an unwanted observer looking over the user's shoulder is unable to understand what is displayed. The obscured region of each display frame may be generated such that the overall look and structure of that region is unchanged, but the content is unintelligible. In this way, the visual experience of the user is not disrupted or distracted by the visual encryption and the eye of the onlooker is not guided to the clear-display region by the visual encryption.

Abstract: Various embodiments of the invention provide human extracellular messengers (EXMES) and polynucleotides which identify and encode EXMES. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of EXMES.

Abstract: There is disclosed a manipulator for positioning an interface of an automatic test system. In an embodiment, the manipulator includes a support device to support the interface. A base portion is in connection to the support device. The base portion includes a rotational adjustment mechanism for moving the support device about an axis of rotation. A planar adjustment mechanism moves the support device within a plane orthogonal to the axis of rotation. There is disclosed a method of positioning an interface unit of an automatic test system. In an embodiment, the method includes moving a support device supporting the interface unit a distance from a docking region of a material handling device; and rotating the support device about an axis of rotation passing through the interface unit. Other embodiments are also disclosed.

Abstract: Various embodiments of the invention provide human cell adhesion and extracellular matrix proteins (CADECM) and polynucleotides which identify and encode CADECM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CADECM.

Abstract: Various embodiments of the invention provide human proteins associated with cell growth, differentiation, and death (CGDD) and polynucleotides which identify and encode CGDD. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CGDD.

Abstract: An ultra lightweight golf club shaft which includes a butt section, a tip section, and a tapered section interconnecting the same. The tapered section can be a constant taper, or include a plurality of step portions interconnected by frustoconical transition areas. The shafts are extremely durable and allow a faster club head speed and a better feel than with the previous prior art shafts.

Abstract: A Various embodiments of the invention provide human nucleic acid-associated proteins (NAAP) and polynucleotides which identify and encode NAAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NAAP.

Abstract: Various embodiments of the invention provide human intracellular signaling molecules (INTSIG) and polynucleotides which identify and encode INTSIG. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of INTSIG.

Abstract: Various embodiments of the invention provide human nucleic acid-associated proteins (NAAP) and polynucleotides which identify and encode NAAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NAAP.

Abstract: Various embodiments of the invention provide human enzymes (ENZM) and polynucleotides which identify and encode-ENZM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of ENZM.

Abstract: Various embodiments of the invention provide human protein modification and maintenance molecules (PMMM) and polynucleotides which identify and encode PMMM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PMMM.a.